Acute liver injury associated with the use of herbal preparations containing glucosamine: Three case studies

BMJ Case Reports

Volumn , Issue , 2009, Pages

  Smith, Aileen ^a   Dillon, John ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84865140361     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr.02.2009.1603     Document Type: Article

References (50)

1. Zollman C, Vickers A. ABC of complementary medicine: users and practitioners of complementary medicine. BMJ 1999; 319: 836-8. [FREE Full text] (Pubitemid 29445925)
2. Zollman C, Vickers A. ABC of complementary medicine: herbal medicine. BMJ 1999; 319: 1050-3. [FREE Full text]
3. Medicines and Healthcare products Regulatory Agency (MHRA). Safety report: Safety of herbal medicinal products. London, UK: Department of Health, 2002.
4. Ernst E. Herbal medicines: where is the evidence? BMJ 2000; 321: 395-6. [FREE Full text] (Pubitemid 30609439)
5. Whiting PW, Clouston A, Kerlin P. Black cohosh and other herbal remedies associated with acute hepatitis. Med J Aust 2002 177; 8: 440-3. Search Google Scholar
6. Georgia M. Hepatotoxicity due to Atractylis gummiferia. Clin Toxicol 1988; 26: 487-93. [CrossRef]
7. Cohen SM, O'Connor AM, Hart J, et al. Autoimmune hepatitis associated with the use of black cohosh: a case study. Menopause 2004; 11: 575-7. [CrossRef] [Medline] (Pubitemid 40362157)
8. Lontos S, Jones RM, Angus PW, et al. Acute liver failure associated with the use of herbal preparations containing black cohosh. Med J Aust 2003; 179: 390-1. [Medline] [Web of Science] (Pubitemid 37265139)
9. Sheikh NM, Philen RM, Love LA. Chaparral-associated hepatotoxicity. Arch Int Med 1997; 157: 913-19. [CrossRef] [Medline] [Web of Science] (Pubitemid 28337043)
10. Batchelor WB, Heathcote J, Wanless IR. Chaparral-induced hepatic injury. Am J Gastroenterol 1995; 90: 831-3. [Medline] [Web of Science]
11. Gordon DW, Rosenthal G, Hart J, et al. Chaparral ingestion: the broadening spectrum of liver injury caused by herbal medications. J Am Med Assoc 1995; 273: 489-90. [CrossRef] [Medline] [Web of Science]
12. Ridker PM, Okuma S, McDermott WV, et al. Hepatic veno-occlusive disease associated with the consumption of pyrrolizidine-containing dietary supplements. Gastroenterology 1985; 88: 1050-4. [Medline] [Web of Science] (Pubitemid 15105901)
13. Miskelly FG, Goodyer LI. Hepatic and pulmonary complications of herbal medicines. Postgrad Med J 1992; 68: 935. [FREE Full text]
14. Larrey D, Vial T, Pauwels A, et al. Hepatitis after germander administration: another instance of herbal medicine hepatotoxicity. Ann Intern Med 1992; 117: 129-32. [CrossRef] [Medline] [Web of Science]
15. Mostefa-Kara N, Pauwels A, Bines E, et al. Fatal hepatitis after herbal tea. Lancet 1992; 340: 674. [CrossRef] [Medline]
16. Ossendza RA, Grandval P, Chinoune F. Hépatite aiguë cholestatique à la Glucosamine Forte. Gastroenterol Clin Biol 2007; 31: 449-50. [Medline] [Web of Science] (Pubitemid 46706837)
17. Fujii H, Takagaki N, Yoh T, et al. Non-prescription supplement-induced hepatitis with hyperferritinaemia and mutation (H63D) in the HFE gene. Hepatol Res 2008; 38: 319-23. [CrossRef] [Medline] [Web of Science] (Pubitemid 351193962)
18. Benninger J, Schneider HT, Schuppan D, et al. Acute hepatitis induced by greater celandine. Gastroenterology 1999; 117: 1234-7. [CrossRef] [Medline] (Pubitemid 29512684)
19. Picciotti A, Campo N, Brizzolara R, et al. Chronic hepatitis induced by Jin Bu Huan. J Hepatol 1998; 28: 165-7. [Medline] [Web of Science] (Pubitemid 28122515)
20. Woolf GM, Petrovic LM, Rojter SE, et al. Acute hepatitis associated with the Chinese herbal product Jin Bu Huan. Ann Intern Med 1994; 121: 729-35. [Medline] [Web of Science]
21. Stickel F, Baumuller HM, Seitz KH, et al. Hepatitis induced by Kava-Kava. J Hepatol 2003; 39: 62-7. [CrossRef] [Medline] [Web of Science]
22. Nadir A, Agrawal S, King PD, et al. Acute hepatitis associated with the use of a Chinese herbal product, Ma Huang. Am J Gastroenterol 1996; 91: 1436-8. [Medline] [Web of Science]
23. Hyde FF. Mistletoe hepatitis. BMJ 1981; 282: 739. [FREE Full text]
24. Farnsworth NR, Loub WD. Mistletoe hepatitis. BMJ 1982; 283: 1058. Search Google Scholar
25. Stirpe F. Mistletoe toxicity. Lancet 1983; 1: 295. [Medline] [Web of Science] (Pubitemid 13184295)
26. Stadlbauer V, Fickert P, Lackner C, et al. Hepatotoxicity of Noni juice: report of two cases. World J Gastroenterol 2005; 11: 4758-60. [Medline] (Pubitemid 41179538)
27. Bakerink JA, Gospe SM, Dimand RJ, et al. Multiple organ failure after ingestion of pennyroyal oil from herbal tea in two infants. Paediatrics 1996; 98: 944-7. [Abstract/FREE Full text] (Pubitemid 26398780)
28. Sullivan JB, Rumack BH, Thomas H, et al. Pennyroyal poisoning and hepatotoxicity. J Am Med Assoc 1979; 242: 2873-4. [CrossRef] [Medline] [Web of Science]
29. Stickel F, Patsenker E, Schuppan D. Herbal hepatotoxicity. J Hepatol 2005; 43: 901-10. [CrossRef] [Medline] [Web of Science] (Pubitemid 41414517)
30. Larrey D. Hepatotoxicity of herbal medicines. J Hepatol 1997; 26(Suppl 1): 47-51. [CrossRef] [Medline]
31. Beuers U, Spengler U, Pape GR. Hepatitis after chronic abuse of senna. Lancet 1991; 337: 372-3. [Medline] [Web of Science]
32. Hullar TE, Sapers BL, Ridker PM, et al. Herbal toxicity and fatal hepatic failure. Am J Med 1999; 106: 267-8. [CrossRef] [Medline] [Web of Science] (Pubitemid 29115973)
33. MacGregor FB, Abernethy VE, Dahabra S, et al. Hepatotoxicity of herbal remedies. BMJ 1989; 299: 1156-7. [FREE Full text] (Pubitemid 19266434)
34. Benichou C. Criteria of drug-induced liver disorders. Report of an International Consensus Meeting. J Hepatol 1990; 11: 272-6. [CrossRef] [Medline] [Web of Science]
35. Danan G, Benichou C. Causality assessment of adverse reactions to drugs: I. A novel method based on the conclusions of international consensus meetings: application to drug induced liver injuries. J Clin Epidemiol 1993; 46: 1323-30. [CrossRef] [Medline] [Web of Science] (Pubitemid 23333873)
36. Aithal GP, Rawlins MD, Day CP. Clinical diagnostic scale: a useful tool in the evaluation of suspected hepatotoxic adverse drug reactions. J Hepatol 2000; 33: 949-52. [CrossRef] [Medline] [Web of Science]
37. Natural Standard Patient Monograph. Glucosamine. http://www.mayoclinic. com/health/glucosamine/NS-patientglucosamine (accessed 2006).
38. Reginster JY, Deroisy R, Rovati LC, et al. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet 2001; 357: 251-6. [CrossRef] [Medline] [Web of Science] (Pubitemid 32120855)
39. Pavelka K, Gatterova J, Olejarova M, et al. Glucosamine sulphate use and delay of progression of knee osteoarthritis: a 3 year, randomised, placebo-controlled, double-blind study. Arch Intern Med 2002; 162: 2113-23. [CrossRef] [Medline] [Web of Science] (Pubitemid 35168220)
40. Rindone JP, Hiller D, Collacot E, et al. Randomised, controlled trial of glucosamine for treating osteoarthritis of the knee. Western J Med 2000; 172: 91-4. [CrossRef] [Medline] [Web of Science]
41. Houpt JB, McMillan R, Wein C, et al. Effect of glucosamine hydrochloride in the treatment of pain of osteoarthritis of the knee. J Rheumatol 1999; 26: 2423-30. [Medline] [Web of Science] (Pubitemid 29528986)
42. Noack W, Fischer M, Forster KK, et al. Glucosamine sulphate in osteoarthritis of the knee. Osteoarthritis Cartilage 1994; 2: 51-9. [CrossRef] [Medline]
43. Drovanti A, Bignamini AA, Rovati AL. Therapeutic activity of oral glucosamine sulphate in osteoarthritis: a placebo-controlled, double-blind investigation. Clin Ther 1980; 3: 260-72. [Medline] [Web of Science] (Pubitemid 11122261)
44. Pujalte JM, Llavore EP, Ylescupidez FR. Double-blind clinical evaluation of oral glucosamine sulphate in the basic treatment of osteoarthritis. Curr Med Res Opin 1980; 7: 110-14. [Medline] [Web of Science] (Pubitemid 11161038)
45. Larrey D. Drug-induced liver diseases. J Hepatol 2000; 32(Suppl 1): 77-88. [Medline] [Web of Science] (Pubitemid 30123626)
46. Chitturi S, Farrell GC. Herbal hepatotoxicity: an expanding but poorly defined problem. J Gastroenterol Hepatol 2000; 15: 1093-109. [CrossRef] [Medline] [Web of Science]
47. Haller CA, Dyer JE, Ko RJ, et al. Making a diagnosis of herbal-related toxic hepatitis. Western J Med 2002; 176: 39-44. [CrossRef] [Medline] [Web of Science]
48. Aithal PG, Day CP. The natural history of histologically proved drug induced liver disease. Gut 1999; 44: 731-5. [Abstract/FREE Full text] (Pubitemid 29195925)
49. Andrade RJ, Lucena MI, Kaplowitz N, et al. Outcome of acute idiosyncratic drug-induced liver injury: long-term follow-up in a hepatotoxicity registry. Hepatology 2006; 44: 1581-8. [CrossRef] [Medline] [Web of Science] (Pubitemid 44953663)
50. Bjornsson E, Davidsdottir L. The long-term follow-up after idiosyncratic drug-induced liver injury with jaundice. J Hepatol 2009; 50: 511-17. [CrossRef] [Medline] [Web of Science]